Table-3.
Existing animal models for the assessment of DM.
Animal model | Type of animals used | Experimental parameters |
---|---|---|
Normoglycemic | Normal healthy animals | Potential oral hypoglycemic agents are tested |
Oral glucose loading model (glucose tolerance testing) | Normal healthy animals | Physiological induction of DM in animals; glucose level is monitored |
Streptozotocin model | Normal healthy animals | Streptozotocin induces DM over a period; provides suitable time intervals and additional information for the mechanism of action of drugs |
Alloxan model | Normal healthy animals | Alloxan induces DM; provides the possibility to produce different grades of severity of DM; provides the blood sugar levels equivalent to total pancreatectomy |
Ferric nitrilotriacetate induced DM model | Normal healthy animals | Measures diabetic symptoms(hyperglycemia, glycosuria, ketonemia, and ketonuria) |
Surgical model | Normal healthy animals | DM is induced in removed pancreas(pancreatectomy); permits to assess if the drug affects resistance to and secretion ofinsulin |
Genetic model | Genetically engineered animals or mutant strains | Longterm complications of DM could be monitored; several drugs could be tested against DM; measures(blood sugar, body weight, insulin production, and insulin resistant); explores the mechanism of action of drugs |
DM=Diabetes mellitus